|
Tinnitus Retraining
Therapy (TRT) is also known as habituation-oriented
therapy. This type of therapy is based upon the
Neurophysiological Origin of Tinnitus first studied
in the 1980s and subsequently published in 1990
by Dr Pawel Jastreboff (Neurosci Res, 1990, 8:221-254).
TRT has been suggested as one method to treat
both tinnitus and hyperacusis. It does not claim
to eliminate the tinnitus, but its goals are to
block the neuronal activity from reaching the
cortex and prevent it from being perceived by
reducing the activation of the Limbic and Autonomic
Nervous Systems. The features of TRT are that:
|
1. |
There
are no harmful side effects. |
| 2. |
It is suitable
for all types of Tinnitus irrespective of
the cause of the Tinnitus / Hyperacusis. |
| 3. |
Research worldwide
has shown an effectiveness of over 80%, significantly
above the placebo effect of 40%. |
| 4. |
TRT requires a
limited treatment period but it is not a “quick-fix”. |
| 5. |
It does not require
frequent visits and the treatment process
easily accommodates out-of-town patients. |
| 6. |
It is the only
treatment that is based upon a scientific
model. |
|
TRT uses a combination of
sound therapy and informational counseling (teaching).
The teaching component demystifies and explains
the condition which will allow the brain to
be rewired so that it can block the perception
of tinnitus. The sound therapy component requires
either the use of hearing aids or sound generators
depending upon the individual’s symptoms.
TRT aims to change first, the reaction to the
tinnitus through its teaching component, and
second, the perception of the tinnitus through
the use of sound therapy. The expected outcomes
are that the patient, even when perceiving tinnitus,
is no longer annoyed by it and a gradual reduction
in the amount of time a person is aware of the
tinnitus. Patients can expect to be in treatment
for 12 to 18 months following which there will
be no further need to continue treatment. Jastreboff
and his associates reported a significant improvement
in over 80% of their patients (Am J Otology,
1996, 17:236-240). Data from our treatment outcomes
reflect similar findings.

|